Parallax Volatility Advisers’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,967
Closed -$10.7K 2260
2023
Q3
$10.7K Sell
10,967
-5,727
-34% -$8.29K ﹤0.01% 2112
2023
Q2
$23.2K Buy
+16,694
New +$23.3K ﹤0.01% 2130
2022
Q1
Sell
-28,178
Closed -$141K 2825
2021
Q4
$141K Buy
+28,178
New +$226K ﹤0.01% 1702
2020
Q3
Sell
-17,800
Closed -$913K 3073
2020
Q2
$913K Buy
+17,800
New +$745K ﹤0.01% 1768
2019
Q3
Sell
-21,763
Closed -$1.01M 2584
2019
Q2
$1.01M Buy
+21,763
New +$1.02M ﹤0.01% 1270
2019
Q1
Sell
-27,653
Closed -$1.27M 3048
2018
Q4
$1.27M Buy
+27,653
New +$1.33M ﹤0.01% 1224
2018
Q3
Sell
-10,655
Closed -$489K 2806
2018
Q2
$418K Buy
+10,655
New +$538K ﹤0.01% 1303
2018
Q1
Sell
-2,562
Closed -$169K 2754
2017
Q4
$169K Sell
2,562
-7,907
-76% -$426K ﹤0.01% 2409
2017
Q3
$525K Buy
10,469
+9,831
+1,541% +$474K ﹤0.01% 1240
2017
Q2
$30K Sell
638
-3,738
-85% -$137K ﹤0.01% 1883
2017
Q1
$155K Buy
+4,376
New +$100K ﹤0.01% 2065

Other funds holding ESPR